American Pharmaceutical Security Act

This bill, known as the "American Pharmaceutical Security Act," mandates that the Administrator of the Centers for Medicare & Medicaid Services (CMS) submit a report to Congress within one year. The report must detail how CMS's coverage and reimbursement authorities can be utilized to protect the markets for active pharmaceutical ingredients (APIs) and key starting materials . A central aim is to reduce the United States' and its allies' reliance on foreign adversaries for these critical components. The report may include recommendations for price floor commitments to bolster domestic manufacturing and suggest prioritizing domestically produced APIs and key starting materials. Furthermore, it is required to identify any existing data and information gaps related to the origin and ownership of these vital pharmaceutical ingredients.